Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> GDC-0853

GDC-0853

GDC-0853 price.
  • $39 - $5888
  • Product name: GDC-0853
  • CAS: 1434048-34-6
  • MF: C37H44N8O4
  • MW: 664.8
  • EINECS:
  • MDL Number:MFCD30489729
  • Synonyms:(S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one;GDC0853;EOS-61209;GDC-0853 (RG7845);GDC-0853;GDC 0853;FENEBRUTINIB (GDC-0853);FENEBRUTINIB;CS-2241
17 prices
Selected condition:
Brand
  • AK Scientific
  • Cayman Chemical
  • Chemenu
  • ChemScene
  • Crysdot
  • DC Chemicals
  • TRC
Package
  • 1mg
  • 2mg
  • 5mg
  • 10mg
  • 25mg
  • 100mg
  • 250mg
  • 1g
  • 5g
  • ManufacturerAK Scientific
  • Product number5696EA
  • Product descriptionFenebrutinib
  • Packaging1mg
  • Price$141
  • Updated2021-12-16
  • Buy
  • ManufacturerAK Scientific
  • Product number5696EA
  • Product descriptionFenebrutinib
  • Packaging5mg
  • Price$298
  • Updated2021-12-16
  • Buy
  • ManufacturerAK Scientific
  • Product number5696EA
  • Product descriptionFenebrutinib
  • Packaging25mg
  • Price$833
  • Updated2021-12-16
  • Buy
  • ManufacturerCayman Chemical
  • Product number21346
  • Product descriptionGDC-0853 ≥98%
  • Packaging1mg
  • Price$39
  • Updated2024-03-01
  • Buy
  • ManufacturerCayman Chemical
  • Product number21346
  • Product descriptionGDC-0853 ≥98%
  • Packaging5mg
  • Price$180
  • Updated2024-03-01
  • Buy
  • ManufacturerCayman Chemical
  • Product number21346
  • Product descriptionGDC-0853 ≥98%
  • Packaging10mg
  • Price$340
  • Updated2024-03-01
  • Buy
  • ManufacturerCayman Chemical
  • Product number21346
  • Product descriptionGDC-0853 ≥98%
  • Packaging25mg
  • Price$647
  • Updated2023-06-20
  • Buy
  • ManufacturerChemenu
  • Product numberCM328221
  • Product description10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one 95%+
  • Packaging1g
  • Price$2208
  • Updated2021-12-16
  • Buy
  • ManufacturerChemenu
  • Product numberCM328221
  • Product description10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one 95%+
  • Packaging5g
  • Price$5888
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-5927
  • Product descriptionFenebrutinib 99.83%
  • Packaging2mg
  • Price$60
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-5927
  • Product descriptionFenebrutinib 99.83%
  • Packaging5mg
  • Price$95
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-5927
  • Product descriptionFenebrutinib 99.83%
  • Packaging10mg
  • Price$170
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-5927
  • Product descriptionFenebrutinib 99.83%
  • Packaging25mg
  • Price$380
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-5927
  • Product descriptionFenebrutinib 99.83%
  • Packaging100mg
  • Price$1150
  • Updated2021-12-16
  • Buy
  • ManufacturerCrysdot
  • Product numberCD00009582
  • Product descriptionGDC-0853 98+%
  • Packaging25mg
  • Price$345
  • Updated2021-12-16
  • Buy
  • ManufacturerDC Chemicals
  • Product numberDC9942
  • Product descriptionGDC-0853(RG7845) >98%
  • Packaging250mg
  • Price$1500
  • Updated2021-12-16
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
AK Scientific 5696EA Fenebrutinib 1mg $141 2021-12-16 Buy
AK Scientific 5696EA Fenebrutinib 5mg $298 2021-12-16 Buy
AK Scientific 5696EA Fenebrutinib 25mg $833 2021-12-16 Buy
Cayman Chemical 21346 GDC-0853 ≥98% 1mg $39 2024-03-01 Buy
Cayman Chemical 21346 GDC-0853 ≥98% 5mg $180 2024-03-01 Buy
Cayman Chemical 21346 GDC-0853 ≥98% 10mg $340 2024-03-01 Buy
Cayman Chemical 21346 GDC-0853 ≥98% 25mg $647 2023-06-20 Buy
Chemenu CM328221 10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one 95%+ 1g $2208 2021-12-16 Buy
Chemenu CM328221 10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one 95%+ 5g $5888 2021-12-16 Buy
ChemScene CS-5927 Fenebrutinib 99.83% 2mg $60 2021-12-16 Buy
ChemScene CS-5927 Fenebrutinib 99.83% 5mg $95 2021-12-16 Buy
ChemScene CS-5927 Fenebrutinib 99.83% 10mg $170 2021-12-16 Buy
ChemScene CS-5927 Fenebrutinib 99.83% 25mg $380 2021-12-16 Buy
ChemScene CS-5927 Fenebrutinib 99.83% 100mg $1150 2021-12-16 Buy
Crysdot CD00009582 GDC-0853 98+% 25mg $345 2021-12-16 Buy
DC Chemicals DC9942 GDC-0853(RG7845) >98% 250mg $1500 2021-12-16 Buy

Properties

Boiling point :936.3±65.0 °C(Predicted)
Density :1.42±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF:20.0(Max Conc. mg/mL);30.08(Max Conc. mM)
DMSO:17.0(Max Conc. mg/mL);25.57(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:2):0.33(Max Conc. mg/mL);0.5(Max Conc. mM)
Ethanol:5.0(Max Conc. mg/mL);7.52(Max Conc. mM) form :A crystalline solid
pka :13.15±0.10(Predicted)
color :White to off-white

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

GDC-0853 is an orally bioavailable, selective, and reversible Bruton’s tyrosine kinase (BTK) inhibitor with IC50s ranging from 2-9 nM for basophil activation, B cell receptor activation, and constitutive p-BTK activity in whole blood lysates. In rats, treatment for longer than 7 days leads to pancreatic toxicity but it does not occur in mice or dogs, even at higher doses. Formulations containing GDC-0853 were well-tolerated in Phase I clinical trials and are in additional clinical trials for rheumatoid arthritis, lupus erythematosus, lymphoma, and leukemia.